Efficacy of oral trazodone slow release following intravenous administration in depressed patients: a naturalistic study.

CONCLUSIONS: This finding confirms previous results on depression with concomitant anxiety symptoms: focusing on trazodone prolonged-release formulation, available data documented its efficacy in MDD. PMID: 30353201 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30353201?dopt=Abstract

Source: Rivista di Psichiatria - October 26, 2018 Category: Psychiatry Tags: Riv Psichiatr Source Type: research